Metraipolis › archive › dc_64274cbbea44

Beneficial effects of upadacitinib on a subgroup of patients with atopic dermatitis and hidradenitis suppurativa: a multicenter, real-world retrospective study — Europe PMC PMID:41822476

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41822476
DOI
10.3389/fimmu.2026.1770969
License (as archived)
solo-consultazione
Archived
2026-11-05T12:35:00.170Z
SHA-256 of the archived text
ae22fe853dbae28bd62ef4b22ffc3a152f84b819aeb2d0e0465a611b369630eb
Stable URL of this page
https://metraipolis.com/documento/dc_64274cbbea44

How to cite

Beneficial effects of upadacitinib on a subgroup of patients with atopic dermatitis and hidradenitis suppurativa: a multicenter, real-world retrospective study — Europe PMC PMID:41822476 — Europe PMC (en), https://europepmc.org/article/MED/41822476 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_64274cbbea44 (Metraipolis archive dc_64274cbbea44, sha256 ae22fe853dbae28bd62ef4b22ffc3a152f84b819aeb2d0e0465a611b369630eb)
BibTeX
@misc{dc64274cbbea44,
  title = {Beneficial effects of upadacitinib on a subgroup of patients with atopic dermatitis and hidradenitis suppurativa: a multicenter, real-world retrospective study — Europe PMC PMID:41822476},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41822476},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_64274cbbea44; sha256 ae22fe853dbae28bd62ef4b22ffc3a152f84b819aeb2d0e0465a611b369630eb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41822476. Agents can read the archived copy with the MCP tool read_document.